UK markets close in 8 hours 12 minutes
  • FTSE 100

    6,980.72
    -15.36 (-0.22%)
     
  • FTSE 250

    22,929.74
    +52.73 (+0.23%)
     
  • AIM

    1,234.73
    +3.62 (+0.29%)
     
  • GBP/EUR

    1.1761
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.3889
    +0.0010 (+0.07%)
     
  • BTC-GBP

    28,531.25
    +1,691.46 (+6.30%)
     
  • CMC Crypto 200

    928.00
    +51.77 (+5.91%)
     
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • DOW

    35,058.52
    -85.79 (-0.24%)
     
  • CRUDE OIL

    72.04
    +0.39 (+0.54%)
     
  • GOLD FUTURES

    1,804.80
    +5.00 (+0.28%)
     
  • NIKKEI 225

    27,581.66
    -388.56 (-1.39%)
     
  • HANG SENG

    25,377.58
    +291.15 (+1.16%)
     
  • DAX

    15,539.09
    +19.96 (+0.13%)
     
  • CAC 40

    6,543.20
    +11.28 (+0.17%)
     

[2877.HK] Shineway Doubles Dividend Payout and Guarantees Compound Increase in Future Annual Dividend Based on Net Profit Growth

·2-min read


EQS-News / 19/07/2021 / 22:06 UTC+8

Shineway Doubles Dividend Payout and Guarantees Compound Increase in Future Annual Dividend Based on Net Profit Growth

 

China Shineway Pharmaceutical Group Limited (stock code: 2877.HK) announced that it has adopted a new dividend policy that would bring impressive cash dividend return to its shareholders and becoming a "cash-cow of sustainable growth". The new dividend policy is summarized as followed:

 

 

 

 

 

 

 

 

Shineway is confident that this new dividend policy which guarantees compound increase in future annual dividend based on net profit growth would attract long-term investors to invest in Shineway's shares.

 

For more details, please contact DLK Advisory by emailing to ir@dlkadvisory.com.

 

19/07/2021 Dissemination of a Financial Press Release, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Media archive at www.todayir.com

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting